دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Frequency and outcomes of STEMI patients presenting between 12 and 24 h after symptom onset: Late-presenting STEMI
Anna C. Gonzalez Griffin MD, Mehmet Yildiz MD, Steven Bradley MD, Jenna E. Smith BS, Santiago Garcia MD, Christian W. Schmidt MS, Ross Garberich MS, Evan Walser-Kuntz MS, Jay Traverse MD, James G. Jollis MD, Scott W. Sharkey MD, Timothy D. Henry MD
doi : 10.1002/ccd.30495
To assess the characteristics and prognosis of ST-elevation myocardial infarction (STEMI) patients, presenting between 12 and 24 h after symptom onset, in contemporary regional STEMI systems of care in the United States.
PCI for late STEMI: Better late than never?
Monique G. Davis DO, James C. Blankenship MD, MHCM, MSCAI
doi : 10.1002/ccd.30538
Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent
Lars Jakobsen MD, PhD, Evald H. Christiansen MD, PhD, Phillip Freeman MD, PhD, Johnny Kahlert PhD, Karsten Veien MD, Michael Maeng MD, PhD, Bent Raungaard MD, PhD, Julia Ellert MD, PhD, Steen D. Kristensen MD, DMSci, Martin K. Christensen MD, Christian J. Terkelsen MD, DMSci, Troels Thim MD, PhD, Ashkan Eftekhari MD, PhD, Rebekka V. Jensen MD, PhD, Nicolaj B. Støttrup MD, PhD, Anders Junker MD, PhD, Henrik S. Hansen MD, DMSci, Lisette O. Jensen MD, DMSci
doi : 10.1002/ccd.30480
To compare the efficacy and safety of the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent (DTS) and the sirolimus-eluting Orsiro stent (O-SES) in patients with and without acute coronary syndrome (ACS) included in the SORT OUT X study.
SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: Insights from the Altshock-2 registry
Nuccia Morici MD, PhD, Simone Frea MD, Maurizio Bertaina MD, Alice Sacco MD, Elena Corrada MD, Carlotta Sorini Dini MD, Martina Briani MD, Michele Tedeschi MD, Francesco Saia MD, Costanza Colombo MD, Matteo Rota, Fabrizio Oliva MD, Mario Iannaccone MD, Gaetano M. De Ferrari MD, Alessandro Sionis MD, Navin K. Kapur MD, Guido Tavazzi MD, Federico Pappalardo MD
doi : 10.1002/ccd.30484
Cardiogenic shock (CS) includes several phenotypes with heterogenous hemodynamic features. Timely prognostication is warranted to identify patients requiring treatment escalation.
Drug-coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study
Juying Qian MD, PhD, Yizhe Wu MD, Chenguang Li MD, PhD, Jiasheng Yin MD, Guosheng Fu MD, Jian'an Wang MD, Yong He MD, Genshan Ma MD, Yundai Chen MD, Yong Xia MD, Lang Li MD, Fusui Ji MD, Hesong Zeng MD, Meng Wei MD, Shaoping Nie MD, Huigen Jin MD, Ben He MD, Yuguo Chen MD, Fan Liu MD, Hui Wang MD, Yingxian Sun MD, Bo Xu MBBS, Junbo Ge MD, the PEPCAD China SVD study
doi : 10.1002/ccd.30472
Whether the drug-coated balloons (DCBs)-alone strategy was superior to plain old balloon angioplasty (POBA) in treating SVD remains unknown.
Multimodality imaging results of TAP versus novel modified TAP stenting in coronary bifurcation: From bench testing to first-in-man investigation
Jaryl Chen Koon Ng PhD, Huiying Ang PhD, Liang Zhong PhD, Diaa Hakim MD, PhD, Kostas Marmagkiolis MD, Nicolas Foin PhD, Massoud A. Leesar MD
doi : 10.1002/ccd.30496
We investigated the results of T and small protrusion (TAP) versus a novel modification of TAP (mTAP) stenting by multimodality imaging in bench testing and in patients with coronary bifurcation lesions (CBL).
Bifurcation stenting: If the shoe doesn't fit
Adib Chaus MD, Barry F. Uretsky MD
doi : 10.1002/ccd.30537
Comparison of outcomes in patients with or without ARC-HBR criteria undergoing PCI with polymer-free biolimus coated stents: The BioFreedom France study
Philippe Garot MD, Philippe Brunel MD, Alain Dibie MD, Jean-François Morelle MD, Mohamed Abdellaoui MD, Raphy Levy MD, Didier Carrié MD, Bernard Karsenty MD, Christophe Robin MD, Jacques Berland MD, Samuel Copt MD, Sara Sadozai Slama MD, Keith Oldroyd MD, Marie-Claude Morice MD, Janusz Lipiecki MD, the BioFreedom France Investigators
doi : 10.1002/ccd.30481
The polymer-free biolimus coated stent (BioFreedom) was shown to be superior to bare metal stents in the LEADERS FREE randomized trial in high bleeding risk (HBR) patients treated with 1-month dual antiplatelet therapy (DAPT). However, there is limited outcome data with this device in an all-comers' population.
Comparison between the diagnostic performance of vessel fractional flow reserve and nonhyperemic pressure ratio for functionally significant coronary stenosis severity as assessed by fractional flow reserve
Kazumasa Ikeda MD, Masatake Kobayashi MD, PhD, Taishiro Chikamori MD, PhD, Yohei Yanaka, Ryu Takagi MD, Junya Kani MD, Outaro Oshima MD, Satoshi Yamada MD, PhD, Yohei Hokama MD, PhD, Nobuhiro Tanaka MD, PhD
doi : 10.1002/ccd.30511
Fractional flow reserve (FFR) and nonhyperemic pressure ratios (NHPRs) have been widely used to assess the functional severity of coronary stenosis. However, their measurement requires using a pressure wire, making their use in all patients difficult. The recently developed vessel fractional flow reserve (vFFR), derived from three-dimensional quantitative coronary angiography, is expected to serve as a surrogate for pressure wire assessment.
A novel comprehensive radiation shielding system eliminates need for personal lead aprons in the catheterization laboratory
Maher Rabah DO, Sorcha Allen MBBChBAO, Amr E. Abbas MD, Simon Dixon MBChB
doi : 10.1002/ccd.30490
This clinical study evaluated the efficacy of a novel radiation shielding system for the cardiac catheterization laboratory designed to provide comprehensive protection that obviates the need for personal lead aprons.
Comparison of radiation exposure associated with transradial and transfemoral access: An updated meta-analysis
Najam Saqib MD, Muhammad S. Pir MD, Sharath Rajagopalan MD, Tejas M. Patel MD, Samir B. Pancholy MD
doi : 10.1002/ccd.30513
To assess differences in radiation exposure between transradial access (TRA) and transfemoral access (TFA) for coronary procedures.
Bail out lithotripsy to treat delayed valve-in-valve TAVR-related coronary obstruction
Brian O. Bingen MD, PhD, Ibtihal Al Amri MD, Jose M. Montero-Cabezas MD, Frank van der Kley MD, PhD
doi : 10.1002/ccd.30483
Coronary access difficulty and stent compression by the juxtaposed aortic valve leaflet hamper percutaneous management of delayed coronary artery obstruction (CAO) after valve-in-valve (Edwards Sapien 3 in St. Jude Trifecta) transcatheter aortic valve replacement (TAVR).
Chronic total occlusion percutaneous coronary intervention in heart transplant patients
Lorenzo Azzalini MD, PhD, MSc, Francesco Moroni MD, Kathryn L. Dawson MD, Kathleen E. Kearney MD
doi : 10.1002/ccd.30476
Cardiac allograft vasculopathy (CAV) is frequently observed after heart transplant (HT), and represents one of the main causes of chronic rejection, graft loss, and death.
Management of a right coronary artery mycotic coronary aneurysm with percutaneous intervention with covered stents
Justin Price MD, Robert Okyere MD, Sadeer Al-Kindi MD, Anjan Gupta MD
doi : 10.1002/ccd.30494
Coronary artery aneurysmal dilation is a rare finding with poorly understood mechanism of action that is found in small population of patients undergoing coronary angiography.
Unrecoverable stent deformation in the left main: Crush it or remove it?
Alexandru Achim MD, Lian Krivoshei MD, Gregor Leibundgut MD
doi : 10.1002/ccd.30482
Serial ostial and distal left main lesions continue to be one of the most difficult tasks for the interventional cardiologist, with many potential complications occurring.
Mechanical circulatory support for cardiogenic shock complicating spontaneous coronary artery dissection
Waseem Nosair MD, MPH, Faris G. Araj MD
doi : 10.1002/ccd.30473
Incorporating economic analysis in interventional cardiology research
Michael L. O'Byrne MD, MSCE, Robert Wilensky MD, Andrew C. Glatz MD, MSCE
doi : 10.1002/ccd.30506
Evaluative research in interventional cardiology has focused on clinical and technical outcomes. Inclusion of economic data can enhance evaluative research by quantifying the relative economic burden incurred by different therapies. When combined with clinical outcomes, cost data can provide a measure of value (e.g., marginal cost-effectiveness).
A word of caution: Early failure of Magmaris® bioresorbable stent after pulmonary artery stenting
Raymond N. Haddad MD, Ahmed Adel Hassan MD, Mahmoud AL Soufi MD, Mohamed Kasem MD
doi : 10.1002/ccd.30487
Bioresorbable scaffolds (BRS) have been advocated as the fourth revolution in interventional cardiology medical devices with promising technology to improve the treatment of coronary artery disease with an event-free future.
Hybrid approach for harmony transcatheter pulmonary valve replacement
Kamel Shibbani MD, Jamil Aboulhosn MD, Daniel Levi MD, Bassel Mohammad Nijres MD, Benjamin Blais MD, Mohsen Karimi MD, Glen Van Arsdell MD, Osamah Aldoss MD
doi : 10.1002/ccd.30504
The Harmonyâ„¢ Transcatheter Pulmonary Valve (Medtronic) was recently approved by the Food and Drug Administration for transcatheter pulmonary valve replacement in native right ventricular outflow tracts. Despite this milestone, some patients have main pulmonary arteries that are severely dilated and continue to require surgical pulmonary valve replacement.
Mechanical thrombectomy versus catheter directed thrombolysis in patients with pulmonary embolism: A multicenter experience
Errol K. Inci MD, Sameer Khandhar MD, Catalin Toma MD, Giancarlo Licitra MPH, Matthew J. Brown MD, Matthew Herzig MD, William Matthai MD, Harold Palevsky MD, Arielle Schwartz MD, John A. Wight MD, Michael McDaniel MD, Gautam Kumar MD, Chandan Devireddy MD, Scott Baumgartner MD, Michael Bashline MD, Wissam A. Jaber MD
doi : 10.1002/ccd.30505
Compare in-hospital outcomes of patients treated with either mechanical thrombectomy (MT) or catheter directed lysis (CDL) in treatment of acute pulmonary embolism (PE).
Risk factors for percutaneous left ventricular assist device explant complications
Jason P. Schott DO, Akash Rusia MD, Stephen Lynch MD, Adam Tawney MD, Syed F. Mustafa MD, Abdalla K. Balla MD, Ivan D. Hanson MD
doi : 10.1002/ccd.30485
Percutaneous left ventricular assist device (pLVAD) explant remains nonstandardized with potential complications of bleeding and thrombosis.
Radial and ulnar approach for carotid artery stenting with Roadsaverâ„¢ double layer micromesh stent: Early and long-term follow-up
Danica Petkoska MD, Biljana Zafirovska MD, PhD, Ivan Vasilev MD, Gabriela Novotni MD, PhD, Olivier F. Bertrand MD, PhD, FSCAI, Sasko Kedev MD, PhD, FSCAI
doi : 10.1002/ccd.30514
We aimed to evaluate the feasibility and safety of carotid artery stenting (CAS) with a newly designed double-layer micromesh stent using wrist approach in patients with significant carotid disease.
Trans-caval aspiration artherectomy/thrombectomy of large mobile plaques and thrombi in aortic arch and descending aorta
Michael Chiang MBBS, Pedro A. Villablanca MD, MSc, William W. O'Neill MD, Tiberio Frisoli MD
doi : 10.1002/ccd.30491
Aspiration thrombectomy with the AngioVac is approved for percutaneous removal of thrombus in the venous system.
Readmission with infective endocarditis within 90 days following transcatheter aortic valve implantation
Takuya Ogami MD, Dustin E. Kliner MD, Catalin Toma MD, Derek Serna-Gallegos MD, Yisi Wang MPH, James A. Brown MD, Sarah Yousef MD, Ibrahim Sultan MD
doi : 10.1002/ccd.30508
Transcatheter aortic valve implantation (TAVI) continues to be the most common modality of treating aortic stenosis in the United States.
50+ years later, prosthetic valve endocarditis still confounds
Peter C. Block MD, MSCAI
doi : 10.1002/ccd.30544
Minimalist transcatheter aortic valve replacement misses paravalvular regurgitation:Â Incidence and echocardiographic distribution of missed paravalvular regurgitation
Syed Zaid MD, Ahmed Abu Haniyeh MD, Akiva Rosenzveig BA, Aaqib Malik MD, Joshua B. Goldberg MD, Cenap Undemir MD, Daniel Spevack MD, Steven L. Lansman MD, PhD, Gilbert H. L. Tang MD, MSc, MBA, Hasan Ahmad MD
doi : 10.1002/ccd.30512
Paravalvular regurgitation (PVR) may be missed intraoperatively with transthoracic echocardiography (TTE) guided minimalist TAVR. We sought to determine the incidence and echocardiographic distribution of PVR missed on intra-op TTE, but detected on predischarge TTE.
Clinical and echocardiographic outcomes with new-onset left bundle branch block after SAPIEN-3 transcatheter aortic valve replacement
Yasser M. Sammour MD, Hassan Lak MD, Johnny Chahine MD, Abdelrahman Abushouk MD, Sanchit Chawla MD, Amer Kadri MD, Feras Alkhalaileh MD, Sachin Kumar MD, Bindesh Ghimire MD, Lars Svensson MD, PhD, Zoran Popovic MD, PhD, Khaldoun Tarakji MD, MPH, Oussama Wazni MD, Grant W. Reed MD, MSc, James Yun MD, PhD, Rishi Puri MD, PhD, Amar Krishnaswamy MD, Samir R. Kapadia MD
doi : 10.1002/ccd.30488
New-onset left bundle branch block (LBBB) can develop after transcatheter aortic valve replacement (TAVR) resulting in worse outcomes.
Nothing to do does not mean any consequences
Tiziana Claudia Aranzulla MD, MSc, Giuseppe Musumeci MD
doi : 10.1002/ccd.30543
Aortic annulus ellipticity and outcomes after transcatheter aortic valve implantation
Daijiro Tomii MD, Taishi Okuno MD, Jonas Lanz MD, MSc, Stefan Stortecky MD, MPH, Stephan Windecker MD, Thomas Pilgrim MD, MSc
doi : 10.1002/ccd.30507
Elliptical shape of the aortic annulus has been associated with an increased risk of device failure after transcatheter aortic valve implantation (TAVI) compared with a circular annular shape.
Single arterial access closure of post-infarction ventricular septal defect: A case series
Ata Doost MD, Ahmed Chilmeran MB, BCh, BAO, Arionilson Gomes BSc, Rafal Dworakowski MBBS, PhD, Mehdi Eskandari MD, Philip MacCarthy BSc, MBChB, PhD, James Cockburn MD, Jonathan Byrne MBChB, PhD, David Hildick-Smith MD
doi : 10.1002/ccd.30510
Post-infarction ventricular septal defect (PIVSD) carries a very poor prognosis. Surgical repair offers reasonable outcomes in patients who survive the initial healing period. Percutaneous device implantation remains a potentially effective earlier alternative.
Right atrial structural remodeling predict worse outcomes in transcatheter mitral valve repair
Matthew S. Miller MD, Jamey Cutts MD, Marissa Donatelle MD, Kajal Shah MD, Fardous Abeya, Nicholas Ashur MD, Edward Rojas MD, Nishaki Mehta MD, Younghoon Kwon MD, Anita Barber, Prince Afriyie Ph.D, Nishtha Sodhi MD, Scott Lim MD, Kenneth Bilchick MD, Sula Mazimba MD
doi : 10.1002/ccd.30471
In the current study, we assess the predictive role of right and left atrial volume indices (RAVI and LAVI) as well as the ratio of RAVI/LAVI (RLR) on mortality following transcatheter mitral valve repair (TMVr).
Telltale atria�The meaning of adverse remodeling
Marvin H. Eng MD, Firas Zahr MD
doi : 10.1002/ccd.30555
Procedural simplification of left atrial appendage occlusion using the VersaCross connect system: First in-human experience
Nils Perrin MD, Cameron McAlister MD, Michael Tsang MD, Blandine Mondésert MD, Réda Ibrahim MD, Jacqueline Saw MD
doi : 10.1002/ccd.30503
Left atrial appendage occlusion (LAAO) has emerged over the last two decades as an efficient and safe alternative to oral anticoagulation for stroke prevention.
BMI and the mortality paradox in patients undergoing cardiovascular procedures�Causation or Association?
Tareq Abu Sharifeh MD, FACC, Hani Jneid MD, FACC, FAHA, FSCAI
doi : 10.1002/ccd.30527
